FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

FONAR CorporationNASDAQ: FONR

Net Change in Cash · Q3 FY2026 · quarter ended Mar 2026

Net change in cash declines year over year

Q3 FY2026 net change in cash of $673K fell 0.1% year over year, ahead of the -320.6% change in trailing-twelve-month net change in cash.

Context

  • Net change in cash amounted to 0.0% of revenue in FY2025, down 4.9 pp from a year earlier.
  • Net change in cash increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -0.1% holds above the trailing-twelve-month pace of -320.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$673K+151.8% QoQ
Last fiscal yearJun 2025
-$7.56K-100.1% YoY
LTMMar 2026
-$607K-320.6% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.1%——
1 year-100.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(7.56K) USD
Year-over-year change
-100.1%

Net Change in Cash vs competitors

How FONR compares with its peers on the latest reported figures

  • Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -320.6% is the 7th highest of 8, against a peer median of +102.0%.
  • Net change in cash amounts to 0.6% of revenue for FONR, versus a peer median of 14.7%.
FONR Competitors
Net Change in Cash for FONR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IFRXInflaRx N.V.LTM Mar 2026€22.84M EUR-203.0%-73.8%77884.9%
LUNGPulmonx CorporationLTM Mar 2026$12.98M USD-393.9%-70.9%14.7%
ARTVArtiva Biotherapeutics, Inc.LTM Mar 2026$9.45M USD-46.3%-38.9%—
HYPRHyperfine, Inc.LTM Mar 2026$7.74M USD+126.1%-71.8%50.5%
VANIVivani Medical, Inc.LTM Mar 2026$6.74M USD+140.5%——
RCELAVITA Medical, Inc.LTM Mar 2026$6.56M USD+215.3%-53.4%9.1%
FONRFONAR CorporationLTM Mar 2026$607K USD-320.6%—0.6%
APYXApyx Medical CorporationLTM Mar 2026$126K USD+102.0%-96.4%0.2%
Peer median (excluding FONR) —+102.0%-71.4%14.7%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income13.67M17.23M12.13M14.1M10.67M
Depreciation & Amortization5.54M8.54M8.8M4.6M4.7M
Deferred Income Tax3.53M3.09M2.98M2.8M823.66K
Stock-Based Compensation83.28K0000
Change in Working Capital(11.26M)(14.21M)(15.17M)(8.62M)(8.19M)
Accounts Receivables(11.91M)(5.56M)(8.12M)(11.62M)(8.98M)
Inventory(14.65K)(696.4K)(209.85K)(145.78K)(97.24K)
Accounts Payables(99.22K)(314.77K)19.69K276.67K(553.56K)
Other Working Capital762.59K(7.64M)(6.86M)2.87M1.44M
Other Non-Cash Items7.53M642.77K5.73M1.22M3.26M
Operating Cash Flow19.09M15.3M14.47M14.09M11.26M
Capital Expenditures(4.82M)(4.63M)(4.34M)(822.85K)(3.82M)
Acquisitions (Net)0(546K)000
Purchases of Investments(293)(149)(473)(103.3K)0
Sales of Investments00000
Other Investing Activities(163.71K)(87.88K)(119.57K)42.53K(9.72K)
Investing Cash Flow(4.82M)(5.18M)(4.34M)(850.74K)(3.8M)
Debt Repayment(40.34K)(37.24K)(36.62K)(44.9K)(113.94K)
Common Stock Issued00000
Common Stock Repurchased00(1.76M)(2.51M)(1.81M)
Dividends Paid00000
Other Financing Activities(6.57M)(5.82M)(5.78M)(5.63M)(5.55M)
Financing Cash Flow(6.61M)(5.86M)(7.57M)(8.18M)(7.47M)
Effect of Forex Changes00000
Net Change in Cash7.66M4.26M2.56M5.06M(7.56K)
Free Cash Flow14.27M10.67M10.13M13.27M7.45M

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.